Ispecimen to participate in maxim's 2022 virtual growth conference on march 28-30, 2022

Lexington, mass., march 15, 2022 (globe newswire) -- ispecimen inc. (nasdaq: ispc) (“ispecimen” or the “company”), a global, proprietary online marketplace connecting scientists with healthcare providers to search for biospecimens needed for medical research, today announced that christopher ianelli, md, phd, ceo and president of ispecimen, will participate in maxim group's 2022 virtual growth conference to be held virtually on march 28-30, 2022.
ISPC Ratings Summary
ISPC Quant Ranking